Stability of autoantibodies and their relation to genetic and metabolic markers of type I diabetes in initially unaffected schoolchildren

Diabetologia

Volumn 43, Issue 4, 2000, Pages 457-464

  Kulmala, P ^a   Rahko, J ^a   Savola, K ^a   Vahasalo P ^a   Veijola, R ^a   Sjoroos M ^b   Reunanen, A ^c   Honen, J ^b   Knip, M ^d  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Autoantibodies; FPIR; HLA; Schoolchildren; Type I diabetes

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; HLA DQ ANTIGEN; INSULIN; INSULIN ANTIBODY; PANCREAS ISLET CELL ANTIBODY;

ALLELE; ARTICLE; CONTROLLED STUDY; GENE; GENOTYPE; HUMAN; IMMUNOFLUORESCENCE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0034047565     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250051329     Document Type: Article

References (48)

1. Dahlquist G, Blom I, Holmgren G et al. (1985) The epidemiology of diabetes in Swedish children 0-14 years: a six-year prospective study. Diabetologia 28: 802-808
2. Tuomilehto J, Lounamaa R, Tuomilehto-Wolf E et al. (1992) Epidemiology of childhood diabetes in Finland: background of a nationwide study of Type I (insulin-dependent) diabetes mellitus. Diabetologia 35: 70-76
3. Kulmala P, Savola K, Petersen JS et al. (1998) Prediction of insulin-dependent diabetes mellitus in siblings of children with diabetes - a population based study. J Clin Invest 101: 327-336
4. + relatives. Diabetes 45: 1720-1728
5. Sorva R, Perheentupa J, Tolppanen EM (1984) A novel format for a growth chart. Acta Paed Scand 73: 527-529
6. Bingley PJ, Colman R Eisenbarth GS et al. (1992) Standardization of IVGTT to predict IDDM. Diabetes Care 15: 1313-1316
7. Andersen L, Dinesen B, Jørgensen PN et al. (1993) Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem 39: 578-582
8. Hjelm M (1969) Enzymatic determination of hexoses in blood and urine. Scand J Clin Lab Invest 192[Suppl]:85-98
9. Bottazzo GF, Florin-Christensen A, Doniach D (1974) Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet ii:1279-1282
10. Greenbaum CJ, Palmer JR Nagataki S et al. (1992) Improved specificity of ICA assays in the fourth international immunology of diabetes serum exchange workshop. Diabetes 41: 1570-1574
11. Savola K, Bonifacio E, Sabbah E et al. (1998) IA-2 antibodies - a sensitive marker of IDDM with clinical onset in children and adolescents. Diabetologia 41: 424-429
12. Verge CF, Stenger D, Bonifacio E et al. (1998) Combined use of autoantibodies (IA-2ab, GADab, IAA, ICA) in type I diabetes: combinatorial islet autoantibody workshop. Diabetes 47: 1857-1866
13. 65 antibodies in relation to other antibodies and genetic risk markers in children with newly diagnosed IDDM. J Clin Endocrinol Metab 81: 2455-2459
14. Williams AJ, Bingley PJ, Bonifacio E, Palmer JR Gale EA (1997) A novel micro-assay for insulin autoantibodies. J Autoimmun 10: 473-478
15. Sjöroos M, Iitiä A, Honen J, Reijonen H, Lövgren T (1995) Triple-label hybridization assay for type-1 diabetes-related HLA alleles. Biotechniques 18: 870-877
16. Honen J, Reijonen H, Herva E et al. (1996) Rapid HLA-DQB1 genotyping for four alleles in the assessment of risk for IDDM in the Finnish population. Diabetes Care 19: 795-800
17. Sjöroos M, Honen J, Reijonen H, Lövgren T (1998) Time-resolved fluorometry based sandwich hybridisation assay for HLA-DQA1 typing. Disease Markers 14: 9-19
18. Schuster J (1988) EXACTB and CONF: exact unconditional procedures for binominal data. American Statistician 42: 234
19. Spencer KM, Tarn A, Dean BM, Lister J, Bottazzo GF (1984) Fluctuating islet cell autoimmunity in unaffected relatives of patients with insulin dependent diabetes. Lancet i:746-766
20. Johnston C, Millward BA, Hoskins R Leslie RD, Bottazzo GF, Pyke DA (1989) Islet-cell antibodies as predictors of the later development of Type I (insulin-dependent) diabetes. A study in identical twins. Diabetologia 32: 382-386
21. Krischer JR Schatz D, Riley WJ et al. (1993) Insulin and islet cell autoantibodies as time-dependent covariates in the development of insulin-dependent diabetes: a prospective study in relatives. J Clin Endocrinol Metab 77: 743-749
22. Bingley PJ, Christie MR, Bonifacio E et al. (1994) Combined analysis of autoantibodies improves prediction of IDDM in islet cell autoantibody-positive relatives. Diabetes 43: 1304-1310
23. Gorus FK, Vandewalle CL, Dorchy H et al. (1994) Influence of age on the associations among insulin autoantibodies, islet cell antibodies, and HLA DQA1*0301-DQB1*0301 in siblings of patients with type 1 (insulin-dependent) diabetes mellitus. J Clin Endocrinol Metab 78: 1172-1178
24. Knip M, Vähäsalo R Karjalainen J, Lounamaa R, Åkerblom HK, the Childhood Diabetes in Finland Study Group (1994) Natural history of preclinical IDDM in high risk siblings. Diabetologia 37: 388-393
25. Roll U, Christie MR, Eberhard S, Ziegler A-G (1994) Associations of anti-GAD antibodies with islet cell antibodies in first-degree relatives of type 1 diabetic patients. Diabetes 43: 154-160
26. Schmidli RS, DeAizpurua HJ, Harrison LC, Colman PG (1994) Antibodies to glutamic acid decarboxylase in at-risk and clinical insulin-dependent diabetic subjects: relationship to age, sex and islet cell antibody status, and temporal profile. J Autoimmun 7: 55-66
27. Schott M, Schatz D, Atkinson MA et al. (1994) GAD65 autoantibodies increase the predictability but not the sensitivity of islet cell and insulin autoantibodies for developing insulin dependent diabetes mellitus. J Autoimmun 7: 865-872
28. Lévy-Marchal C, Dubois F, Noël M, Tichet J, Czernichow P (1995) Immunogenetic determinants and prediction of IDDM in French schoolchildren. Diabetes 44: 1029-1032
29. Roll U, Christie MR, Füchtenbusch M, Payton MA, Hawkes CJ, Ziegler AG (1996) Perinatal autoimmunity in offspring of diabetic parents. The German multicenter BABY-DIAB study: detection of humoral immune responses to islet antigens in early childhood. Diabetes 45: 967-973
30. Yu L, Rewers M, Gianani R (1996) Antiislet autoantibodies usually develop sequentially rather than simultaneously. J Clin Endocrinol Metab 81: 4264-4267
31. Christie MR, Roll U, Payton MA, Hatfield EC, Ziegler AG (1997) Validity of screening for individuals at risk for type I diabetes by combined analysis of antibodies to recombinant proteins. Diabetes Care 20: 965-970
32. Hawa M, Rowe R, Lan MS et al. (1997) Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type 1 diabetes. Diabetes 46: 1270-1275
33. Landin-Olsson M, Karlsson A, Dahlquist G, Blom L, Lernmark A, Sundquist G (1989) Islet cell and other organ-specific autoantibodies in all children developing Type I (insulin-dependent) diabetes mellitus in Sweden during one year and in matched control children. Diabetologia 32: 387-395
34. Boehm BO, Seissler J, Gluck M et al. (1991) The level and the persistence of islet cell antibodies in healthy schoolchildren are associated with polymorphic residues of the HLA-DQβ chain. Dis Markers 9: 273-280
35. Seissler J, Hering B, Richter W et al. (1992) Antibodies to the Mr 64,000 (64K) protein in islet cell antibody positive non-diabetic individuals indicate high risk for impaired beta-cell function. Diabetologia 35: 550-554
36. Lévy-Marchal C, Tichet J, Fajardy I, Gu XF, Dubois F, Czernichow P (1992) Islet cell antibodies in normal French school-children. Diabetologia 35: 577-582
37. Bingley PJ, Bonifacio E, Shattock M et al. (1993) Can islet cell antibodies predict IDDM in the general population? Diabetes Care 16: 45-50
38. 65 combined with islet cell cytoplasmic antibodies for predicting IDDM in a childhood population. Diabetologia 37: 917-924
39. Bingley PJ, Bonifacio E, Williams AJ, Genovese S, Bottazzo GF, Gale EA (1997) Prediction of IDDM in the general population. Strategies based on combinations of autoantibody markers. Diabetes 46: 1701-1710
40. Robert JJ, Deschamps I, Chevenne D, Roger M, Mogenet A, Boitard C (1991) Relationship between first-phase insulin secretion and age, HLA, islet cell antibody status, and development of type 1 diabetes in 220 juvenile first-degree relatives of diabetic patients. Diabetes Care 14: 718-723
41. Verge CF, Gianani R, Kawasaki E et al. (1996) Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/Ia-2 autoantibodies. Diabetes 45: 926-933
42. Greenbaum CJ, Sears KL, Kahn SE, Palmer JP (1999) Relationship of β-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes. Follow-up of the Seattle Family Study. Diabetes 48: 170-175
43. Strebelow M, Schlosser M, Ziegler B, Rjasanowski I, Ziegler M (1999) Karlsburg Type I diabetes risk study of a general population: frequencies and interactions of the four major Type I diabetes-associated autoantibodies studied in 9419 schoolchildren. Diabetologia 42: 661-670
44. Raghu R Johnston C, Beard JC, Bergman R, McCulloch DK, Palmer JP (1985) Reduced insulin sensitivity in non-diabetic, HLA-identical siblings of insulin-dependent diabetic subjects. Diabetes 34: 991-994
45. Lindgren F, Dahlquist G, Efendic S et al. (1987) Glucose-induced insulin response and insulin sensitivity is not related to HLA-type but to age in young siblings of Type I (insulin-dependent) diabetic patients. Diabetologia 30: 727-732
46. Veijola R, Vähäsalo R Tuomilehto-Wolf E et al. (1995) Human leukocyte antigen identity and DQ risk alleles in autoantibody-positive siblings of children with IDDM are associated with reduced early insulin response. Diabetes 44: 1021-1028
47. Reijonen H, Ilonen J, Knip M, Åkerblom HK (1981) HLA-DQB1 alleles and absence of Asp57 susceptibility factors of IDDM in Finland. Diabetes 40: 1640-1644
48. Komulainen J, Kulmala R Savola K et al. (1999) Clinical, autoimmune and genetic characteristics of very young children with type 1 diabetes. Diabetes Care 22: 1950-1955